Surgical Innovations Group

SUN · AIM · Health Care · mcap £3.7m · 0.4p

Beta Briefing, track record and bull & bear case are not ready for Surgical Innovations Group yet.

We follow 817 UK small caps and every one of their announcements – often hundreds per company. 38 companies are already wired into a briefing: browse them.

Financials · LTM to 30 Jun 26

Source: results 30 Sep 26 ↗

Revenue: £11.5m
Operating profit: −£1.0m
Net income: −£1.2m
Free cash flow: £488k
Net cash: £361k
Market cap: £3.7m
EV / EBIT: –
FCF yield: +13.1%
Price / book: 0.5×

Latest half-year · H1 26 vs H1 25 results 30 Sep 26 ↗

Revenue: £6.0m
Operating profit: −£230k
Net income: −£248k
Cash from operations: £200k

Extracted automatically from the company's results announcements; check the source before relying on a figure. Not investment advice.

Income statement Cash flow Balance sheet

Annual Half-yearly

Latest report: H1 26 (six months to 30 Jun 26), published 30 Sep 26 · read the results ↗

£m unless stated · newest first · italic = calculated (LTM, H2 = FY − H1) · hover a value for its source

	LTM Jun 26	FY 25	FY 24
Revenue	11.5	11.6	–
Gross profit	2.9	3.1	–
Adjusted EBITDA	(0.6)	(0.2)	–
Operating profit	(1.0)	(0.7)	–
Depreciation (owned assets)	0.2	0.2	0.3
Depreciation (right-of-use)	0.3	0.3	0.2
Amortisation	0.1	(0.0)	–
Finance costs	(0.0)	(0.1)	0.1
Profit before tax	(1.2)	(0.9)	–
Tax	–	(0.0)	(0.1)
Net income (owners)	(1.2)	(0.9)	(1.9)
EPS basic	(0.1p)	(0.1p)	–
EPS diluted	(0.1p)	(0.1p)	–

	H1 26	vs H1 25	H2 25	H1 25
Revenue	6.0	−2%	5.5	6.1
Gross profit	1.7	−9%	1.1	1.9
Adjusted EBITDA	0.0	−91%	(0.6)	0.4
Operating profit	(0.2)	n/m	(0.8)	0.1
Depreciation (owned assets)	0.1	−12%	0.1	0.1
Depreciation (right-of-use)	0.1	−1%	0.1	0.1
Amortisation	(0.0)	−70%	0.1	(0.1)
Finance costs	(0.0)	n/m	(0.0)	(0.0)
Profit before tax	(0.2)	n/m	(1.0)	0.0
Net income (owners)	(0.2)	n/m	(0.9)	0.0
EPS basic	(0.0p)	–	(0.1p)	0.0p
EPS diluted	(0.0p)	–	(0.1p)	0.0p

	LTM Jun 26	FY 25	FY 24
Cash from operations	1.0	0.6	(0.1)
Interest paid	(0.0)	(0.1)	(0.1)
Capex (PP&E)	(0.0)	(0.1)	(0.1)
Capex (intangibles)	(0.2)	(0.2)	(0.3)
Lease principal paid	(0.3)	(0.3)	(0.3)

	H1 26	vs H1 25	H2 25	H1 25
Cash from operations	0.2	n/m	0.8	(0.2)
Interest paid	(0.0)	n/m	(0.0)	(0.0)
Capex (PP&E)	(0.0)	n/m	(0.0)	(0.0)
Capex (intangibles)	(0.1)	n/m	(0.1)	(0.1)
Lease principal paid	(0.1)	+1%	(0.2)	(0.1)

	Latest Jun 26	FY 25	FY 24
Other intangibles	5.5	5.4	–
Property, plant & equipment	0.5	0.6	0.7
Inventories	1.7	2.2	3.0
Trade receivables	2.2	2.1	2.2
Cash	0.4	0.8	0.2
Current assets	4.3	5.1	5.3
Total assets	10.9	11.6	12.2
Trade payables	2.4	2.8	1.6
Borrowings, current	0.0	0.1	0.4
Lease liabilities, current	0.3	0.2	0.2
Current liabilities	2.8	3.4	2.8
Lease liabilities, non-current	0.3	0.3	0.5
Total liabilities	3.5	4.0	3.7
Total equity	7.4	7.6	8.5
Net cash / (debt) ex leases	(0.3)	(0.3)	–
Net cash / (debt) incl. leases	(0.9)	(0.8)	–
Shares in issue	–	932.8m	932.8m

	H1 26	H2 25	H1 25	H2 24
Other intangibles	5.5	5.4	5.5	–
Property, plant & equipment	0.5	0.6	0.6	0.7
Inventories	1.7	2.2	2.6	3.0
Trade receivables	2.2	2.1	2.6	2.2
Cash	0.4	0.8	0.1	0.2
Current assets	4.3	5.1	5.3	5.3
Total assets	10.9	11.6	12.1	12.2
Trade payables	2.4	2.8	2.0	1.6
Borrowings, current	0.0	0.1	0.3	0.4
Lease liabilities, current	0.3	0.2	0.1	0.2
Current liabilities	2.8	3.4	2.9	2.8
Lease liabilities, non-current	0.3	0.3	0.5	0.5
Total liabilities	3.5	4.0	3.5	3.7
Total equity	7.4	7.6	8.6	8.5
Net cash / (debt) ex leases	(0.3)	(0.3)	(0.8)	–
Net cash / (debt) incl. leases	(0.9)	(0.8)	(1.4)	–
Shares in issue	–	932.8m	–	932.8m

Line items extracted automatically from each results announcement; when a later report restates a period, the later figure is shown. LTM and H2 are calculated from reported periods. Check the source before relying on a figure.

Company filings. Not investment advice.